Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.
CITATION STYLE
Salgado, M. E. F., Sutor, B., Albright, R. C., & Frye, M. A. (2014). Every reason to discontinue lithium. International Journal of Bipolar Disorders. SpringerOpen. https://doi.org/10.1186/s40345-014-0012-y
Mendeley helps you to discover research relevant for your work.